These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35276582)
1. Artemisinin derivative TPN10466 suppresses immune cell migration and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis. Liu G; Jiang X; Han M; Lv J; Zhuang W; Xie L; Zhang Y; Wang C; Saimaier K; Yang J; Shen J; Li N; Du C Cell Immunol; 2022 Mar; 373():104500. PubMed ID: 35276582 [TBL] [Abstract][Full Text] [Related]
2. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis. Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618 [TBL] [Abstract][Full Text] [Related]
3. The novel small molecule TPN10518 alleviates EAE pathogenesis by inhibiting AP1 to depress Th1/Th17 cell differentiation. Xie L; Lv J; Saimaier K; Han S; Han M; Wang C; Liu G; Zhuang W; Jiang X; Du C Int Immunopharmacol; 2023 Oct; 123():110787. PubMed ID: 37591119 [TBL] [Abstract][Full Text] [Related]
4. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis. Shen R; Deng W; Li C; Zeng G Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476 [TBL] [Abstract][Full Text] [Related]
6. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration. de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850 [TBL] [Abstract][Full Text] [Related]
7. TPN10466 ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting ERK/JNK/p38 signaling pathway. Liu G; Zhang Y; Han S; Zhuang W; Lv J; Han M; Xie L; Jiang X; Wang C; Saimaier K; Shen J; Du C Eur J Immunol; 2023 Apr; 53(4):e2250100. PubMed ID: 36648433 [TBL] [Abstract][Full Text] [Related]
8. Novel phloroglucinol derivative Compound 21 protects experimental autoimmune encephalomyelitis rats via inhibiting Th1/Th17 cell infiltration. Zhao Z; Bao XQ; Zhang Z; Li F; Liu H; Zhang D Brain Behav Immun; 2020 Jul; 87():751-764. PubMed ID: 32173452 [TBL] [Abstract][Full Text] [Related]
9. Artemisinin therapeutic efficacy in the experimental model of multiple sclerosis. Khakzad MR; Ganji A; Ariabod V; Farahani I Immunopharmacol Immunotoxicol; 2017 Dec; 39(6):348-353. PubMed ID: 28952817 [TBL] [Abstract][Full Text] [Related]
10. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS. Kong W; Li H; Tuma RF; Ganea D Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422 [TBL] [Abstract][Full Text] [Related]
11. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System. Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B Front Immunol; 2019; 10():2436. PubMed ID: 31681316 [TBL] [Abstract][Full Text] [Related]
12. Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis. Kuo PC; Brown DA; Scofield BA; Paraiso HC; Wang PY; Yu IC; Yen JH Brain Behav Immun; 2018 May; 70():76-87. PubMed ID: 29604346 [TBL] [Abstract][Full Text] [Related]
13. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis. Lee J; Choi J; Lee W; Ko K; Kim S Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735 [TBL] [Abstract][Full Text] [Related]
14. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis. Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167 [TBL] [Abstract][Full Text] [Related]
15. Anlotinib attenuates experimental autoimmune encephalomyelitis mice model of multiple sclerosis Zhu H; Li G; Yin J; Zhang H; Da Y; Li L Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):594-602. PubMed ID: 35638564 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA223 promotes pathogenic T-cell development and autoimmune inflammation in central nervous system in mice. Satoorian T; Li B; Tang X; Xiao J; Xing W; Shi W; Lau KH; Baylink DJ; Qin X Immunology; 2016 Aug; 148(4):326-38. PubMed ID: 27083389 [TBL] [Abstract][Full Text] [Related]
17. Magnolol as STAT3 inhibitor for treating multiple sclerosis by restricting Th17 cells. Chen JY; Tian XY; Wei SS; Xu W; Pan RR; Chen LL; Chen LD; Nan LH; Yao-Lin ; Shan-Deng ; Wang QQ; Ma XQ; Huang MQ Phytomedicine; 2023 Aug; 117():154917. PubMed ID: 37301184 [TBL] [Abstract][Full Text] [Related]
18. The Effect of Aqueous Extract of Tarragon on Clinical Symptoms and T Cell Differentiation in Experimental Autoimmune Encephalomyelitis. Nowras T; Fereidouni M; Safari H; Naseri M Iran J Allergy Asthma Immunol; 2019 Oct; 18(5):523-532. PubMed ID: 32245296 [TBL] [Abstract][Full Text] [Related]
19. Total Flavonoids of Astragalus Inhibit Activated CD4[Formula: see text] T Cells and Regulate Differentiation of Th17/Th1/Treg Cells in Experimental Autoimmune Encephalomyelitis Mice by JAK/STAT and NF[Formula: see text]B Signaling Pathways. Han XY; Xu N; Yuan JF; Wu H; Shi HL; Yang L; Wu XJ Am J Chin Med; 2023; 51(5):1233-1248. PubMed ID: 37385966 [TBL] [Abstract][Full Text] [Related]
20. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation. Xie L; Gong W; Chen J; Xie HW; Wang M; Yin XP; Wu W Int Immunopharmacol; 2018 Sep; 62():227-236. PubMed ID: 30031314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]